Unité de Psychologie Clinique Développementale

Chantal Michel

Chantal_Michel_photo.jpgMaître-assistante, chercheure invitée

Uni Mail - 6e étage - M6154

Tél. +41 22 379 93 49

Chantal Michel

 Grades universitaires

  • Doctorat en Psychologie, Université de Berne (2014)
  • Formation en neuropsychologie, Université de Zurich (2009-2011)
  • Master en psychologie clinique et neuropsychologie, Université de Berne (2009)
  • Erasmus à Salamanca (ES), Universidad Pontificia de Salamanca
  • Bachelor en psychologie, Université de Fribourg (2006)

Titre de la thèse

"Early detection of psychosis in clinical practice - a combined psychopathological and neurocognitive approach"

Domaines de recherche

Détection précoce des psychoses, neuropsychologie en relation avec les troubles mentaux, épidémiologie des troubles mentaux


Articles publiés

Originalia (* indicates co-first authorship)


Michel C*, Ruhrmann S*, Schimmelmann BG, Klosterkötter J, Schultze-Lutter F (2017). Course of Clinical High Risk States for Psychosis Beyond Conversion. European Archives of Psychiatry and Clinical Neuroscience, doi:10.1007/s00406-016-0764-8.

Hakim A, Slotboom J, Lieger O, Schlittler F, Giger R, Michel C, Wiest R, Wagner F (2017) Clinical evaluation of the iterative metal artefact reduction algorithm for post-operative CT examination after maxillofacial surgery. Dentomaxillofacial Radiology, 46:20160355.

Fey W, Moggi F, Rhode K, Michel C, Seitz A, Stein M (2017). Development of stimulus material for research in alcohol use disorders. International Journal of Methods in Psychiatric Research, 26(1).

2016    Flückiger R*, Ruhrmann S*, Debbané M, Michel C, Hubl D, Schimmelmann BG, Klosterkötter J, Schultze-Lutter F (2016). Psychosis-predictive value of self-reported schizotypy in a clinical high risk sample. Journal of Abnormal Psychology, 125(7):923-932.

Michel C, Schimmelmann BG, Schultze-Lutter F (2016). Demographic and Clinical Characteristics of Diagnosed and Non-Diagnosed Psychotic Disorders in the Community. Early Intervention in Psychiatry, doi:10.1111/eip.12360.

Kindler J, Schultze-Lutter F, Michel C, Martz-Irngartinger A, Linder C, Schmidt SJ, Stegmayer K, Schimmelmann BG, Walther S (2016). Abnormal involuntary movements are linked to psychosis-risk in children and adolescents: results of a population-based study. Schizophrenia Research, 174(1-3):58-64.

Michel C, Kutschal C, Schimmelmann BG, Schultze-Lutter F (2016). Convergent and concurrent validity of the Frankfurt Complaint Questionnaire as a screener for psychosis risk. Journal of Risk Research, doi:10.1080/13669877.2016.1179209.

Lüdtke J, In-Albon T, Michel C, Schmid M (2016). Predictors for DSM-5 nonsuicidal self-injury in female adolescent inpatients: the role of childhood maltreatment, alexithymia, and dissociation. Psychiatry Research, 239:346-352.

2015    Schultze-Lutter F, Michel C, Schmidt SJ, Schimmelmann BG, Maric NP, Salokangas RKR, Riecher-Rössler A, van der Gaag M, Nordentoft M, Raballo A, Meneghelli A, Marshall M, Morrison A, Ruhrmann S, Klosterkötter J (2015). EPA guidance on the early detection of clinical high risk states of psychoses. European Psychiatry, 30:405-416.

Schimmelmann BG, Michel C, Martz-Irngartinger A, Linder C, Schultze-Lutter F(2015). Age matters in the prevalence and clinical significance of ultra-high-risk for psychosis symptoms and criteria in the general population: findings from the BEAR and BEARS-Kid studies. World Psychiatry, 14(2):189-197.

Schultze-Lutter F*, Rahman J*, Ruhrmann S, Michel C, Schimmelmann BG, Maier W, Klosterkötter J (2015). Prevalence of unspecific prodromal and at-risk mental states, and help-seeking in prodromal and early psychosis in first-admission psychosis patients. Social Psychiatry and Psychiatric Epidemiology, 50(12):1831-1841.

2014    Schultze-Lutter F, Michel C, Ruhrmann S, Schimmelmann BG (2014). Prevalence and clinical significance of DSM-5-Attenuated Psychosis Syndrome in adolescents and young adults in the general population: The Bern Epidemiological At-Risk (BEAR) study. Schizophrenia Bulletin, 40(6):1499-1508.

Michel C, Schimmelmann BG, Kupferschmid S, Siegwart M, Schultze-Lutter F (2014). Reliability of telephone assessments of at-risk criteria of psychosis: a comparison to face-to-face interviews. Schizophrenia Research, 153(1-3):251-253. (Letter to the Editors)

Michel C*, Ruhrmann S*, Schimmelmann BG, Klosterkötter J, Schultze-Lutter F (2014). A stratified model for psychosis prediction in clinical practice. Schizophrenia Bulletin, 40(6):1533-1542.

Schmidt SJ, Grunert VM, Schimmelmann BG, Schultze-Lutter F, Michel C (2014). Differences in coping, self-efficacy, and external control beliefs between patients at-risk for psychosis and patients with first-episode psychosis. Psychiatry Research, 219(1):95–102.

Büttner M, Schlittler FL, Michel C, Exadaktylos AK, Iizuka T (2014). Is the black eye a useful sign of facial fractures in patients with minor head injuries? – A retrospective analysis in a level I trauma centre over 10 Years. British Journal of Oral and Maxillofacial Surgery, 52(6):518-522.

2012    Schultze-Lutter F, Klosterkötter J, Michel C, Winkler K, Ruhrmann S (2012). Personality disorders and accentuations in at-risk persons with and without conversion to first-episode psychosis. Early Intervention in Psychiatry, 6(4):389-398.

Schöttle D, Schimmelmann BG, Conus P, Cotton SM, Michel C, McGorry PD, Karow A, Naber D, Lambert M (2012). Differentiating schizoaffective and bipolar I disorder in first-episode psychotic mania. Schizophrenia Research, 40(1-3):31-36.

2011    Schimmelmann BG, Michel C, Schaffner N, Schultze-Lutter F (2011). What percentage of people in the general population satisfy the current clinical at-risk criteria of psychosis? Schizophrenia Research, 125(1):99-100. (Letter to the Editors)

Reviews (peer-reviewed)


Cabrera SAS, Michel C, Lizardo C (2017). Estados clínicos de alto riesgo para esquizofrenia y otras formas de psicosis: una breve revisión. Revista de neuro-psiquiatría 80(1):43-60.


Schultze-Lutter F, Debbané M, Theodoridou A, Wood SJ, Raballo A, Michel C, Schmidt SJ, Kindler J, Ruhrmann S, Uhlhaas PJ (2016). Revisiting the basic symptom concept: Toward translating risk symptoms for psychosis into neurobiological targets. Frontiers in Psychiatry, 7(9):1-15.


Schultze-Lutter F, Schimmelmann BG, Ruhrmann S, Michel C (2013). „A rose is a rose is a rose“ – but at-risk criteria differ. Psychopathology, 46(2):75-87.

Book Chapters


Schultze-Lutter F, Michel C, Klosterkötter J (2017). Nutzen-Risiko-Abschätzung bei der Prävention psychischer Störungen. In: Klosterkötter J, Maier W (Hrsg.). Handbuch Präventive Psychiatrie. Stuttgart; Schattauer: 399-418.


Schultze-Lutter F, Michel C, Schimmelmann BG (2015). Psychosen. In: Rössler W, Ajdacic-Gross V (Hrsg.). Prävention psychischer Störungen. Konzepte und Umsetzungen. Stuttgart; Kohlhammer: 120-130.


Vilagrà R, Michel C, Schultze-Lutter F, Barrantes-Vidal N (2014). Los síntomas básicos como marcadores de riesgo precoz de psicosis. In: Obiols JE, Barrantes-Vidal N (coords.). Signos de riesgo y detección precoz de psicosis. Madrid; Editorial Síntesis S.A.: 133-149.


Schultze-Lutter F, Michel C, Ruhrmann S, Klosterkötter J, Schimmelmann BG (2011). Prediction and Early Detection of First-Episode Psychosis. In: Ritsner M (ed.). Textbook of Schizophrenia Spectrum Disorders, Volume II.Dordrecht; Springer Science+Business Media B.V.: 207-268.

Comments / Editorials (not part of an editored special issue)


Michel C, Toffel E, Schmidt SJ, Eliez S, Armando M, Solida-Tozzi A, Schultze-Lutter F, Debbané M (2017). Détection et traitement précoce des sujets à haut risque clinique de psychose : définitions et recommandations. Encéphale, doi.org/10.1016/j.encep.2017.01.005. (Perspectives/Opinion)


Michel C, Schultze-Lutter F, Schimmelmann BG (2014). Screening instruments in child and adolescent psychiatry: general and methodological considerations. European Child and Adolescent Psychiatry, 23(9):725-727. (Editorial)